Founded in France as a spinout from Sorbonne University, OXIProteomics – a QIMA Life Sciences company is a biotech CRO specializing in biomarker discovery and assessment using advanced proteomics. The company develops innovative, animal-free models to support efficacy evaluation in skin care, dermo-cosmetics, food supplements and medical devices, as well as environmental biomonitoring, with a strong scientific focus on longevity and healthy aging.
OXIProteomics provides biomarker-driven research services.
Services include:
Skin and hair efficacy testing using proteomics
Industries served include:
Cosmetics and dermo-cosmetics
Personal care and wellness
Medical devices
Environmental monitoring
OXIProteomics is distinguished by its advanced proteomic expertise and commitment to animal-free, human-relevant research models. Its scientific approach delivers deep molecular insights that support product performance, innovation and claim substantiation.
OXIProteomics operates in accordance with recognized scientific and quality standards applicable to biomarker research and analytical biotechnology.
As part of QIMA Life Sciences, OXIProteomics strengthens QIMA’s biomarker-based efficacy testing and advanced biotech research capabilities.
Contact our team to learn more about OXIProteomics’ services within QIMA Life Sciences.